Anatomic Pathology Market Trends and Forecast
The future of the global anatomic pathology market looks promising with opportunities in the hospital, research laboratory, and diagnostic laboratory markets. The global anatomic pathology market is expected to reach an estimated $36.3 billion by 2028 with a CAGR of 6.1% from 2023 to 2028. The major drivers for this market are growing geriatric population, high frequency of cancer and other targeted diseases, and increasing adoption of clinical biomarkers to fix disease pathogenesis at the molecular level, which helps in clinical decision-making and improving patient outcomes.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Anatomic Pathology Market by Segment
The study includes trends and forecast for the global anatomic pathology market by product, application, end use industry, and region, as follows:
Anatomic Pathology Market by Product [Shipment Analysis by Value from 2017 to 2028]:
-
Instruments
-
Consumables
-
Services
Anatomic Pathology Market by Application [Shipment Analysis by Value from 2017 to 2028]:
-
Disease Diagnosis
-
Drug Discovery and Development
-
Others
Anatomic Pathology Market by End Use Industry [Shipment Analysis by Value from 2017 to 2028]:
-
Hospitals
-
Research Laboratories
-
Diagnostic Laboratories
-
Others
Anatomic Pathology Market by Region [Shipment Analysis by Value from 2017 to 2028]:
-
North America
-
Europe
-
Asia Pacific
-
The Rest of the World
List of Anatomic Pathology Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies anatomic pathology companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the anatomic pathology companies profiled in this report include:
-
Danaher Corporation
-
PHC Holdings
-
Quest Diagnostics
-
F. Hoffmann-La Roche
-
Agilent Technologies
-
Cardinal Health
-
Sakura Finetek
-
NeoGenomics Laboratories
-
BioGenex
Anatomic Pathology Market Insights
-
Lucintel forecasts that consumables will remain the largest segment over the forecast period due to increasing adoption of consumables in research findings owing to its cost effectiveness and easy availability of pathology consumables.
-
Hospitals will remain the largest segment because of the increasing hospitalization rate of cancer patients, growing adoption of in-house diagnostic procedures performed in hospitals as well as rising number of initiatives undertaken by the public and private agencies to promote advanced healthcare systems.
-
North America will remain the largest region over the forecast period due to, increasing awareness towards regular health screening, favorable reimbursement scenarios for diagnostic tests, government initiatives for cancer screening, and existence of key players in the region.
Features of the Anatomic Pathology Market
-
Market Size Estimates: Anatomic pathology market size estimation in terms of value ($B)
-
Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
-
Segmentation Analysis: Anatomic pathology market size by various segments, such as by product, application, end use industry, and region
-
Regional Analysis: Anatomic pathology market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
-
Growth Opportunities: Analysis on growth opportunities in different by product, application, end use industry, and regions for the anatomic pathology market.
-
Strategic Analysis: This includes M&A, new product development, and competitive landscape for the anatomic pathology market.
-
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the anatomic pathology market size?
Answer: The global anatomic pathology market is expected to reach an estimated $36.3 billion by 2028.
Q2. What is the growth forecast for anatomic pathology market?
Answer: The global anatomic pathology market is expected to grow with a CAGR of 6.1% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the anatomic pathology market?
Answer: The major drivers for this market are growing geriatric population, high frequency of cancer and other targeted diseases, and increasing adoption of clinical biomarkers to fix disease pathogenesis at the molecular level, which helps in clinical decision-making and improving patient outcomes.
Q4. What are the major segments for anatomic pathology market?
Answer: The future of the global anatomic pathology market looks promising with opportunities in the hospital, research laboratory, and diagnostic laboratory markets.
Q5. Who are the key anatomic pathology companies?
Answer: Some of the key anatomic pathology companies are as follows:
-
Danaher Corporation
-
PHC Holdings
-
Quest Diagnostics
-
F. Hoffmann-La Roche
-
Agilent Technologies
-
Cardinal Health
-
Sakura Finetek
-
NeoGenomics Laboratories
-
BioGenex
Q6. Which anatomic pathology segment will be the largest in future?
Answer: Lucintel forecasts that consumables will remain the largest segment over the forecast period due to increasing adoption of consumables in research findings owing to its cost effectiveness and easy availability of pathology consumables.
Q7. In anatomic pathology market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to, increasing awareness towards regular health screening, favourable reimbursement scenarios for diagnostic tests, government initiatives for cancer screening, and existence of key players in the region.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.